Vivos Therapeutics VVOS SEC Filings

NASDAQ VVOS
$0.13 -0.01 (-4.20%)
At close: Oct 21, 2026 · 4:00 PM EDT
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Vivos Therapeutics, Inc. (VVOS) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
18-KCurrent Report0001493152-26-047841Oct 21, 2026 7:00 AM-
2PRE 14AOthers0001493152-26-047606Oct 19, 2026 12:58 AM
38-KCurrent Report0001493152-26-047601Oct 19, 2026 12:49 AM
48-KCurrent Report0001493152-26-047158Oct 15, 2026 8:45 AM
58-KCurrent Report0001493152-26-045193Oct 1, 2026 5:54 AM
64Insider Transaction0001493152-26-043443Sep 18, 2026 12:20 AM
74Insider Transaction0001493152-26-043441Sep 18, 2026 12:17 AM
84Insider Transaction0001493152-26-043383Sep 18, 2026 9:04 PM
98-K/AOthers0001493152-26-041807Sep 8, 2026 5:29 PM
108-KCurrent Report0001493152-26-041616Sep 8, 2026 10:26 PM
11SCHEDULE 13GBeneficial Ownership Report0001851416-26-000030Sep 3, 2026 8:48 PM
124Insider Transaction0001493152-26-040238Aug 26, 2026 8:10 PM
138-KCurrent Report0001493152-26-039736Aug 21, 2026 9:30 PM
1410-QQuarterly & Annual Report0001493152-26-038336Aug 14, 2026 8:07 PM
158-KCurrent Report0001493152-26-037173Aug 11, 2026 5:02 PM
16SCHEDULE 13GBeneficial Ownership0001851416-26-000026Aug 11, 2026 1:28 PM
178-KCurrent Report0001493152-26-035867Aug 3, 2026 5:29 PM
18SCHEDULE 13DBeneficial Ownership Report0001104659-26-083931Jul 15, 2026 9:07 PM
194Insider Transaction0001193125-26-304815Jul 15, 2026 8:23 PM
203Insider Transaction0001193125-26-304807Jul 15, 2026 8:22 PM
218-KCurrent Report0001493152-26-032387Jul 7, 2026 9:29 PM
228-KCurrent Report0001493152-26-030190Jun 25, 2026 9:22 PM
238-KCurrent Report0001493152-26-028912Jun 16, 2026 9:03 PM
248-KCurrent Report0001493152-26-028775Jun 16, 2026 11:44 PM
258-KCurrent Report0001493152-26-027641Jun 8, 2026 12:30 PM
2610-QQuarterly & Annual Report0001493152-26-024650May 20, 2026 9:05 PM
27NT 10-QQuarterly & Annual Report0001493152-26-023733May 15, 2026 8:05 PM
28SCHEDULE 13GBeneficial Ownership Report0001172661-26-002126May 15, 2026 3:05 PM
29EFFECTOthers9999999995-26-001555May 8, 2026 4:15 AM
30EFFECTOthers9999999995-26-001555May 8, 2026 4:15 AM
31EFFECTOthers9999999995-26-001555May 8, 2026 4:15 AM
32424B3Prospectus0001493152-26-022022May 8, 2026 9:10 PM
33424B3Prospectus0001493152-26-022022May 8, 2026 9:10 PM
34424B3Prospectus0001493152-26-022022May 8, 2026 9:10 PM
35S-3Prospectus0001493152-26-019693Apr 30, 2026 7:15 PM
368-KCurrent Report0001493152-26-018562Apr 22, 2026 4:25 PM
378-KCurrent Report0001493152-26-016865Apr 15, 2026 9:15 PM
3810-KQuarterly & Annual Report0001493152-26-016854Apr 15, 2026 9:00 PM
393Insider Transaction0002114460-26-000002Apr 10, 2026 8:54 PM
403Insider Transaction0002114460-26-000002Apr 10, 2026 8:54 PM
413Insider Transaction0002114460-26-000002Apr 10, 2026 8:54 PM
428-KCurrent Report0001493152-26-015132Apr 3, 2026 8:05 PM
434Insider Transaction0002074003-26-000008Apr 2, 2026 11:34 PM
444Insider Transaction0002074003-26-000008Apr 2, 2026 11:34 PM
454Insider Transaction0002074003-26-000008Apr 2, 2026 11:34 PM
46SCHEDULE 13DBeneficial Ownership Report0001104659-26-039298Apr 2, 2026 10:32 PM
47NT 10-KQuarterly & Annual Report0001493152-26-014114Mar 31, 2026 8:01 PM
48S-3Prospectus0001493152-26-006829Feb 17, 2026 12:17 AM
493Insider Transaction0001493152-26-006835Feb 13, 2026 1:36 AM
503Insider Transaction0001493152-26-006835Feb 13, 2026 1:36 AM
...

Vivos Therapeutics, Inc. SEC Filings API

Pull Vivos Therapeutics, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=VVOS&formtype=10-K,10-Q&api_key=YOUR_API_KEY